A brief review of the addition of gonadotropin-releasing hormone agonists (GnRH-Ag) to growth hormone (GH) treatment of children with idiopathic growth hormone deficiency: Previously published studies from America

Molecular and Cellular Endocrinology

Volumn 254-255, Issue , 2006, Pages 221-225

  Reiter, Edward O ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Gonadotropin releasing hormone agonist therapy; Growth hormone; Idiopathic growth hormone deficiency; Near adult height; Pubertal maturation

Indexed keywords

GONADORELIN AGONIST; GROWTH HORMONE;

BODY HEIGHT; BONE GROWTH; BONE MATURATION; CATCH UP GROWTH; CORRELATION ANALYSIS; GROWTH HORMONE DEFICIENCY; HUMAN; NORTH AMERICA; PRACTICE GUIDELINE; PRECOCIOUS PUBERTY; PREPUBERTY; PRIORITY JOURNAL; PUBERTY; REGISTER; SEX RATIO; SHORT STATURE; SHORT SURVEY; TREATMENT OUTCOME; WESTERN HEMISPHERE;

AGE DETERMINATION BY SKELETON; BODY HEIGHT; CHILD; CLINICAL TRIALS; DRUG THERAPY, COMBINATION; DWARFISM, PITUITARY; GONADOTROPIN-RELEASING HORMONE; GROWTH HORMONE; HUMANS; NORTH AMERICA; REGISTRIES;

EID: 33745912824     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2006.04.024     Document Type: Short Survey

References (50)

1. Antoniazzi F., Bertoldo F., Zamboni G., Valentini R., Sirpresi S., Cavallo L., Adami S., and Tato L. Bone mineral metabolism in girls with precocoious puberty during gonadotrophin-releasing hormone agonist treatment. Eur. J. Endocrinol. 133 4 (1995) 412-417
2. Attie K.M., Ramirez N.R., Conte F.A., Kaplan S.L., and Grumbach M.M. The pubertal growth spurt in eight patients with true precocious puberty and growth hormone deficiency: evidence for a direct role of sex steroids. J. Clin. Endocrinol. Metab. 71 4 (1990) 975-983
3. August G.P., Julius J.R., and Blethen S.L. Adult height in children with growth hormone deficiency who are treated with biosynthetic grwoth hormone: the National Cooperative Growth Study experience. Pediatrics 102 2(Pt3) (1998) 512-516
4. Balducci R., Toscano V., Mangiantini A., Municchi G., Vaccaro F., and Picone S. Adult height in short normal adolescent girls treated with gonadotropin-releasing hormone analog and growth hormone. J. Clin. Endocrinol. Metab. 80 (1995) 3596-3600
5. Bernasconi S., Arrigo T., Wasniewsk M., Ghizzoni L., Ruggeri C., Di Pasquale G., Vottero A., and de Luca F. Long-term results with growth hormone therapy in idiopathic hypopituitarism. Horm. Res. 53 1 (2000) 55-59
6. Birnbacher R., Riedl S., and Frisch H. Long-term treatment in children with hypopituitarism: pubertal development and final height. Horm. Res. 49 (1998) 80-85
7. Blethen S.L., Baptista J., Kuntze J., Foley T., LaFranchi S., Johanson A., and Genentech Growth Study Group. Adult height in growth hormone (GH)-deficient children treated with biosynthetic GH. J. Clin. Endocrinol. Metab. 82 (1997) 418-420
8. Bourguignon J.P., Vandeweghe M., Vanderschuren-Lodeweyckx M., Malvaux P., Wolter R., DuCaju M., and Ernould C. Pubertal growth and final height in hypopituitary boys: a minor role of bone age at onset of puberty. J. Clin. Endocrinol. Metab. 63 (1986) 376-382
9. Bramswig J.H., Schlosser H., and Kiese K. Final height in children with growth hormone deficiency. Horm. Res. 43 (1995) 126-128
10. Burns E.C., Tanner J.M., Preece M.A., and Cameron N. Final height and pubertal development in 55 children with idiopathic growth hormone deficiency, treated for between 2 and 15 years with human growth hormone. Eur. J. Pediatr. 137 (1981) 155-164
11. Cara J.F., Kreiter M.L., and Rosenfield R.L. Height prognosis of children with true precocious puberty and growth hormone deficiency: effect of combination therapy with gonadotropin releasing hormone agonist and growth hormone. J. Pediatr. 120 5 (1992) 709-715
12. Carel J.C. Can we increase adolescent growth?. Eur.J Endocrinol. 151 Suppl. 3 (2004) U101-U108
13. Carel J.C., Lahlou N., Roger M., and Chaussain J.L. Precocious puberty and statural growth. Hum. Reprod. Update 10 2 (2004) 135-147
14. Codner E., Mericq V., and Cassorla F. Optimizing growth hormone therapy during puberty. Horm. Res. 48 Suppl. 5 (1997) 16-20
15. Conn P.M., and Crowley Jr. W.F. Gonadotropin-releasing hormone and its analogs. Annu. Rev. Med. 45 (1994) 391-405
16. Cutfield W.S., Lindberg A., Albertsson-Wikland K., Chatelain P., Ranke M.B., Wilton P., and KIGS International Board. Final height in idiopathic growth hormone deficiency: the KIGS experience. Acta Paediatr. Suppl. 428 (1999) 72-75
17. Cutfield W.S., Lindberg A., Chatelain P., Price D.A., Albertsson-Wikland K., Wilton P., and Ranke M.B. Final height following growth hormone treatment of idiopathic growth hormone deficiency in KIGS. In: Ranke M.B., and Wilton P. (Eds). Growth hormone Therapy in KIGS-10 Years' Experience (1999), Johann Ambrosius Barth Verlag, Heidelberg-Leipzig 93-110
18. de Luca F., Maghnie M., Arrigo T., Lombardo F., Messina M.F., and Berasconi S. Final height otcome of growth hormone-deficient patients treated since less than five years of age. Acta Paediatr. 85 (1996) 1167-1171
19. Dunkel L., and Wickman S. Novel treatment of short stature with aromatase inhibitors. J. Steroid. Biochem. Mol. Biol. 86 3-5 (2003) 345-356
20. Frisch H., and Birnbacher R. Final height and pubertal development in children with growth hormone deficiency after long-term treatment. Horm. Res. 43 (1995) 132-134
21. Grumbach M.M. Estrogen, bone, growth and sex: a sea change in conventional wisdom. J. Pediatr. Endocrinol. Metab. 13 (2000) 1439-1455
22. Grumbach M.M., Bin-Abbas B.S., and Kaplan S.L. The growth hormone cascade: progress and long-term results of growth hormone treatment in growth hormone deficiency. Horm. Res. 49 Suppl. 2 (1998) 41-57
23. Heger S., Partsch C.-J., and Sippell W.G. Long-term outcomes after depot gonadotrophin-releasing hormone agonist treatment of central precocious puberty: final height, body proportions, body composition, bone mineral density, and reproductive function. J. Clin. Endocrinol. Metab. 84 12 (1999) 4583-4590
24. Hibi I., Tanaka T., Tanae A., Kagawa J., Hashimoto N., Yoshizawa A., and Shizume K. The influence of gonadal function and the effect of gonadal suppression treatment on final height in growth hormone (GH)-treated GH-deficient children. J. Clin. Endocrinol. Metab. 69 (1989) 221-226
25. Job J.C., Toublanc J.E., and Landier F. Growth of short normal children in puberty treated for three years with growth hormone alone or in association with gonadotropin-releasing hormone agonist. Horm. Res. 41 (1994) 177-184
26. Klein K.O., Barnes K.M., Jones J.V., Feuillan P.P., and Cutler Jr. G.B. Increased final height in precocious puberty after long-term treatment with LHRH agonists: the National Institutes of Health experience. J. Clin. Endocrinol. Metab. 86 10 (2001) 4711-4716
27. Kohn B., Julius J.R., and Blethen S.L. Combined use of growth hormone and gonadotropin-releasing hormone analogues: the National Cooperative Growth Study Experience. Pediatrics 104 4 (Suppl.) (1999) 1014-1017
28. Lee P.A. The effects of manipulation of puberty on growth. Horm. Res. 60 Suppl. 1 (2003) 60-67
29. MacGillivray M.H., Blethen S.L., Buchlis J.G., Clopper R.R., Sandberg D.E., and Conboy T.A. Current dosing of growth hormone in children with growth hormone deficiency: how physiologic?. Pediatrics 102 2 Pt 3 (1998) 527-530
30. Mauras N., Attie K.M., Reiter E.O., Saenger P., Baptista J., and The Genentech I.C.S.G. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. J. Clin. Endocrinol. Metab. 85 10 (2000) 3653-3660
31. Mericq M.V., Eggers M., Avila A., Cutler G.B.J., and Cassorla F. Near final height in pubertal growth hormone (GH)-deficient patients treated with GH alone or in combination with luteinzing hormone-releasing hormone analog: results of a prospective, randomized trial. J. Clin. Endocrinol. Metab. 85 2 (2000) 569-573
32. Mul D., Wit J.M., Oostdijk W., Van den Broeck J., and Dutch Advisory Group on Growth Hormone. The effect of pubertal delay by GnRH agonist in GH-deficient children on final height. J. Clin. Endocrinol. Metab. 86 10 (2001) 4655-4656
33. Partsch C.-J., Heger S., and Sippell W.G. Management and outcome of central precocious puberty. Clin. Endocrinol. (Oxf) 56 (2002) 129-148
34. Pasquino A.M., Municchi G., Pucarelli I., Segni M., Mancini M.A., and Troiani S. Combined treatment with gonadotropin-releasing hormone analog and growth hormone in central precocious puberty. J. Clin. Endocrinol. Metab. 81 (1996) 948-951
35. Paul D., Conte F.A., Grumbach M.M., and Kaplan S.L. Long-term effect of gonadotropin-releasing hormone agonist therapy on final and near-final height in 26 children with true precocious puberty treated at a median age of less than 5 years. J. Clin. Endocrinol. Metab. 80 2 (1995) 546-551
36. Price D.A., and Ranke M.B. Final height following growth hormone treatment. In: Ranke M.B., and Gunnarsson R. (Eds). Progress in Growth Hormone Therapy-5 Years of KIGS (1994), J&J Verlag, Mannheim 129-144
37. Ranke M.B., and Lindberg A. Early-onset idiopathic growth hormone deficiency within KIGS. Horm. Res. 60 Suppl. 1 (2003) 18-21
38. Ranke M.B., Lindberg A., Martin D.D., Bakker B., Wilton P., Albertsson-Wikland K., Cowell C.T., Price D.A., and Reiter E.O. The mathematical model for total pubertal growth in idiopathic growth hormone (GH) deficiency suggests a moderate role of GH dose. J. Clin. Endocrinol. Metab. 88 10 (2003) 4748-4753
39. Ranke M.B., Price D.A., Albertsson-Wikland K., Maes M., and Lindberg A. Factors determining pubertal growth and final height in growth hormone treatment of idiopathic growth hormone deficiency. Horm. Res. 48 (1997) 62-71
40. Reiter E.O., and Rosenfeld R.G. Normal and aberrant growth. In: Larsen P.R., et al. (Ed). Williams Textbook of Endocrinology. 10th ed. (2002), Saunders, Philadelphia, PA 1003-1114
41. Saggese G., Pasquino A.M., Bertelloni S., Baroncelli G.I., Battinin R., Pucarelli I., Segni M., and Franchi G. Effect of combined treatment with gonadotropin releasing hormone analogue and growth hormone in patients with central precocious puberty who had subnormal growth velocity and impaired height prognosis. Acta Paediatr. 84 (1995) 299-304
42. Severi F. Final height in children with growth hormone deficiency. Horm. Res. 43 (1995) 138-140
43. Turpin A.L., Jacobson J.D., Karmazin H.M., Moore W.V., and Popovic J. Effect of letrozole treatment on skeletal maturation in females. Horm. Res. 62 Suppl. 2 (2004) 149-155
44. van der Sluis I.M., Boot A.M., Krenning E.P., Drop S.L., and de Muinck Keizer-Schrama S.M. Longitudinal follow-up of bone density and body composition in children with precocious or early puberty before, during, and after cessation of GnRH agonist therapy. J. Clin. Endcorinol. Metab. 87 2 (2002) 506-512
45. Walvoord E.C., and Pescovitz O.H. Combined use of growth hormone and gonadotropin-eleasing hormone analogues in precocious puberty: theoretic and practical considerations. Pediatrics 104 (1999) 1010-1014
46. Wickman S., Sipila I., Ankarberg-Lindgren C., Norjavaara E., and Dunkel L. A specific aromatase inhibitor and potential increase in adult height in boys with delayed puberty: a randomised controlled trial. Lancet 357 9270 (2001) 1743-1748
47. Wit J.M., Balen H.V., Kamp G.A., and Oostdijk W. Benefit of postponing normal puberty for improving final height. Eur. J. Endocrinol. 151 Suppl. 1 (2004) S41-S45
48. Wit J.M., Kamp G., and Rikken B. Spontaneous growth and response to growth hormone treatment in children with growth hormone deficiency and idiopathic short stature. Pediatr. Res. 39 (1996) 295-302
49. Wyatt D. Lessons from the national cooperative growth study. Eur. J. Endocrinol. 151 Suppl. 1 (2004) S55-S59
50. Yanovski J.A., Rose S.R., Municchi G., Pescovitz O.H., Hill S.C., Cassorla F.G., and Cutler Jr. G.B. Treatment with a luteinizing hormone-releasing hormone agonist in adolescents with short stature. N. Engl. J. Med. 348 10 (2003) 908-917